HOOD
Robinhood Markets, Inc.
HOOD's fundamentals are mixed, but it looks cheap: trading at 38x earnings, below its usual 51x. Analysts expect strong earnings growth, though they disagree widely on how much.
HRZN
Horizon Technology Finance Corporation
There isn't enough reported data to score HRZN yet.
HOOD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
HOOD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOOD.
HRZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
HRZN's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HRZN.
HOOD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $81.35 | — |
| Cheap | 37x | $78.84 | -3.1% |
| Current | 38x | $81.35 | — |
| Fair | 51x | $110 | +35% |
| Expensive | 74x | $160 | +96% |
Historical ranges are pointers, not guarantees.
HOOD's PE is in its cheap range at 38x. If earnings grow as analysts expect, today's price would be 30x next year's earnings.
HRZN PE Valuation
HRZN has no meaningful PE right now: it lost money over the past year.
HOOD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
HOOD has the edge over HRZN on the outlook, with more favorable earnings and profitability expectations.
HRZN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HRZN's revenue to grow, but its profitability to weaken.
HOOD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.72 | +26% |
| Q3 2026 | $2.16 | -10% |
| Q2 2026 | $2.26 | +15% |
| Q1 2026 | $2.06 | +18% |
| Q4 2025 | $2.05 | +31% |
| Q3 2025 | $2.40 | +314% |
| Q2 2025 | $1.96 | +513% |
| Q1 2025 | $1.75 | +1150% |
| Q4 2024 | $1.56 | +$2.17 |
HOOD has the edge over HRZN on earnings quality, reporting a profit while its opponent remains loss making.
HRZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.74 | — |
| Q3 2026 | -$0.65 | +$0.04 |
| Q2 2026 | $0.46 | +$1.51 |
| Q1 2026 | $0.53 | +$0.72 |
| Q4 2025 | -$0.06 | -108% |
| Q3 2025 | -$0.69 | -196% |
| Q2 2025 | -$1.05 | -213% |
| Q1 2023 | $1.36 | +9.7% |
| Q4 2022 | $1.06 | -24% |
HRZN is still losing money, but less than at its worst: $0.65 per share over the past year, against $1.05 at its worst in mid-2025.
HOOD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +32% |
| Q1 2026 | $1.1B | +15% |
| Q4 2025 | $1.3B | +27% |
| Q3 2025 | $1.3B | +100% |
| Q2 2025 | $989M | +45% |
| Q1 2025 | $927M | +50% |
| Q4 2024 | $1B | +115% |
HRZN has the stronger quarterly revenue trend. Revenue is up 12% for HOOD versus up 16% for HRZN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | -5.9 points |
| Q2 2026 | 54% | +9.5 points |
| Q1 2026 | 39% | -1.5 points |
| Q4 2025 | 52% | -3.5 points |
| Q3 2025 | 50% | +26 points |
| Q2 2025 | 45% | +17 points |
| Q1 2025 | 40% | +14 points |
| Q4 2024 | 55% | +49 points |
HOOD's operating margin was 44% last quarter, down 5.9 points from the same quarter a year ago.
HRZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $13M | +16% |
| Q1 2022 | $8.3M | -16% |
| Q4 2021 | $7.1M | +19% |
| Q3 2021 | $17.1M | +12099% |
| Q2 2021 | $11.1M | -2.2% |
| Q1 2021 | $10M | +303% |
| Q4 2020 | $6M | -41% |
HRZN's revenue is growing: $13M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 60% | -1.3 points |
| Q1 2022 | 43% | -18 points |
| Q4 2021 | 35% | -8.6 points |
| Q3 2021 | 75% | +2397 points |
| Q2 2021 | 61% | -8.6 points |
| Q1 2021 | 61% | +90 points |
| Q4 2020 | 44% | -25 points |
| Q3 2020 | -2321% | N/A |
HRZN's operating margin was 60% last quarter, down 1.3 points from the same quarter a year ago.
HOOD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +$2.8B |
| Q2 2026 | $720M | -79% |
| Q1 2026 | $2B | +217% |
| Q4 2025 | -$937M | +$463M |
| Q3 2025 | -$1.6B | -187% |
| Q2 2025 | $3.5B | +6398% |
| Q1 2025 | $642M | +$1.3B |
| Q4 2024 | -$1.4B | -246% |
HOOD has the edge over HRZN on cash flow, with more consistent year-over-year improvement.
HRZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2M | -98% |
| Q2 2026 | $123.5M | +149% |
| Q1 2026 | -$42.1M | -$28.9M |
| Q4 2025 | -$30.4M | -$4.3M |
| Q3 2025 | $50.6M | +$78.9M |
| Q2 2025 | $49.6M | -8.6% |
| Q1 2025 | -$13.2M | -426% |
| Q4 2024 | -$26.1M | -333% |
HRZN's free cash flow was $52M over the past year, down 14% from the year before. Free cash flow isn't a meaningful measure for financial services companies like HRZN.
HOOD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1M shares |
| 1 year | -0.8% | -6.9M shares |
| 3 years | +1.8% | +15.9M shares |
| 5 years | +292% | +679M shares |
| Available history | +7.2% | +60.8M shares |
HOOD has the edge over HRZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $414M |
| Q1 2026 | $250M |
| Q4 2025 | $100M |
| Q3 2025 | $107M |
| Q2 2025 | $124M |
| Q1 2025 | $322M |
| Q4 2024 | $160M |
HOOD spent $789M buying back its own shares over the past year, up 11% from the year before.
HRZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +1.3M shares |
| 1 year | +61% | +25.1M shares |
| 3 years | +123% | +36.6M shares |
| 5 years | +234% | +46.5M shares |
| Available history | +347% | +51.5M shares |
HRZN has 66M diluted shares, up 61% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
HOOD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -3.3x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
HOOD has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like HOOD.
HRZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 11.5x | High |
| Q1 2022 | 9.1x | High |
| Q4 2021 | 7.7x | High |
| Q3 2021 | 8.3x | High |
| Q2 2021 | 15.5x | High |
| Q1 2021 | 12.6x | High |
| Q4 2020 | 25.3x | High |
| Q3 2020 | 11.9x | High |
HRZN's net debt is about 12 years of its operating earnings (EBITDA), down from 16 years a year ago. Net leverage isn't a meaningful measure for financial services companies like HRZN.
HOOD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 9.5 | Oversold |
HOOD's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
HRZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.5 | Neutral |
| Stochastic | 12.2 | Oversold |
HRZN's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
HOOD PE vs Financial Services Sector
| Metric | HOOD | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 22 | 66 | 44 pts below |
HOOD is trading at 38x earnings, a 189% premium to the Financial Services sector's median of 13x.
HRZN PE vs Financial Services Sector
| Metric | HRZN | Sector median | Relative |
|---|---|---|---|
| PE | 8.9x | 13x | 32% below |
| PE % | 14 | 63 | 49 pts below |
HRZN has the edge over HOOD on valuation relative to its sector.
HOOD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.8 | 17% below |
| 20 week MA | $102.2 | 20% below |
| 50 week MA | $95.4 | 15% below |
| 100 week MA | $88.5 | 8.1% below |
| 200 week MA | $52.1 | 56% above |
HOOD has the edge over HRZN on trend strength, trading above more of its moving averages.
HRZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.23 | 11% below |
| 20 week MA | $4.51 | 17% below |
| 50 week MA | $4.95 | 24% below |
| 100 week MA | $6.40 | 41% below |
| 200 week MA | $9.08 | 59% below |
HRZN is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
HOOD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $35.2 | $18.9 | -46% |
| 2022 | $18.9 | $7.95 | -58% |
| 2023 | $7.95 | $12.7 | +60% |
| 2024 | $12.7 | $39.0 | +206% |
| 2025 | $39.0 | $118.1 | +203% |
| 2026 YTD | $118.1 | $81.4 | -31% |
HOOD has the edge over HRZN on returns for 2026, with the stronger performance.
HRZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $13.0 | +4.9% |
| 2021 | $13.0 | $15.8 | +22% |
| 2022 | $15.8 | $11.6 | -26% |
| 2023 | $11.6 | $13.2 | +13% |
| 2024 | $13.2 | $9.00 | -32% |
| 2025 | $9.00 | $6.34 | -30% |
| 2026 YTD | $6.34 | $3.76 | -41% |
HRZN has finished lower in three of the last six years. It's down 41% so far in 2026.